Regulation 132 Amendment of regulation 156 (article 126a authorisations)F1 I1

United Kingdom

In regulation 156—

(a)

in paragraph (1)—

(i)

after “126a authorisation for” insert “sale or supply of”;

(ii)

after “medicinal product” insert “in Northern Ireland only,”;

(b)

in paragraph (2), after “is in force” insert “in Northern Ireland”;

(c)

in paragraph (3), after “traditional herbal registration” insert “to be in force in Northern Ireland”;

(d)

in paragraph (4) for “the United Kingdom” substitute “Northern Ireland”; and

(e)

in paragraph (5) for “another member State” substitute “an EU member State”.

Annotations

F1: Regs. 132, 132A substituted for reg. 132 (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 99

I1: Reg. 132 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1